Study of CO2 Exchange Patterns During Robotic Prostatectomies



Status:Active, not recruiting
Conditions:Prostate Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:8/2/2018
Start Date:August 2016
End Date:March 2019

Use our guide to learn which trials are right for you!

A Comparative Study of CO2 Exchange Patterns Between Valve-free Trocar (AirSeal®) Versus Standard Trocar (Endopath®) During Robotic Prostatectomies

The AirSeal® System will allow for lower CO2 absorption rates than the Xcel® System.
Furthermore, lower variance in pneumoperitoneal pressure will allow for less "over-pressure"
events and peritoneal stretch, which may reduce postoperative pain.

The primary observation to be made is the level of PaCO2 in the arterial blood, specifically
when the patient is insufflated and deflated during the surgery. As a result of the
consistent pressure that the AirSeal® system maintains, CO2 will be absorbed in lower levels
when compared to the standard of care systems in which fluctuations in intra-peritoneum
pressure are seen. Therefore, higher pressures will result in higher levels of CO2 exchange
in the blood, leading to increased vasodilation and lower pH levels.

Inclusion Criteria:

- Age>18

- Eligible and elect to undergo robotic prostatectomy surgery @ OhioHealth Dublin
Methodist Hospital

Exclusion Criteria:

- Age < 18

- Emergency surgery

- Ascites

- BMI>44 or <18
We found this trial at
1
site
Columbus, Ohio 43016
Principal Investigator: Ronney Abaza, MD,FACS
Phone: 614-544-8430
?
mi
from
Columbus, OH
Click here to add this to my saved trials